Mark David Charles
11Patents
4h-index
33Co-inventors
60Inventor score
Filing activity: Feb 4, 2000 → Apr 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6893650B1 | N2-phenylamidine derivatives | Chemistry; Metallurgy | 15 | Expired |
| US10040788B2 | 1,3,4-thiadiazole compounds and their use in treating cancer | Chemistry; Metallurgy | 5 | Active |
| US9938265B2 | 1,3,4-thiadiazole compounds and their use in treating cancer | Human Necessities | 4 | Active |
| US10323028B2 | 1,3,4-thiadiazole compounds and their use in treating cancer | Human Necessities | 4 | Active |
| US10294221B2 | 1, 3, 4-thiadiazole compounds and their use in treating cancer | Chemistry; Metallurgy | 3 | Active |
| US11020396B2 | Pyrimidinone derivatives as Cdc7 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10981904B2 | 1,3,4-thiadiazole compounds and their use in treating cancer | Human Necessities | 1 | Active |
| US12358886B2 | Heterocyclic compounds for use in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11753405B2 | 1,3,4-thiadiazole compounds and their use in treating cancer | Human Necessities | 0 | Active |
| US11766434B2 | Pyrimidinone derivatives as CDC7 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10919896B2 | Preparation and uses of pyrimidinone derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.